"Chemokine CCL20" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR6 RECEPTORS. It has activity towards DENDRITIC CELLS; T-LYMPHOCYTES; and B-LYMPHOCYTES.
| Descriptor ID |
D054418
|
| MeSH Number(s) |
D12.644.276.374.200.110.880 D12.644.276.374.200.600.880 D12.776.467.374.200.110.880 D12.776.467.374.200.600.880 D23.125.300.110.880 D23.125.300.600.880 D23.469.200.110.880 D23.469.200.600.880 D23.529.374.200.110.880 D23.529.374.200.600.880
|
| Concept/Terms |
Chemokine CCL20- Chemokine CCL20
- CCL20, Chemokine
- Exodus-1 Chemokine
- Chemokine, Exodus-1
- Exodus 1 Chemokine
- Small Inducible Cytokine A20
- MIP-3-alpha
- SCYA20 Chemokine
- Chemokine, SCYA20
- CCL20 Chemokine
- Chemokine, CCL20
- Macrophage Inflammatory Protein 3 alpha
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL20".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL20".
This graph shows the total number of publications written about "Chemokine CCL20" by people in this website by year, and whether "Chemokine CCL20" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL20" by people in Profiles.
-
Th9 cells promote antitumor immune responses in vivo. J Clin Invest. 2012 Nov; 122(11):4160-71.
-
CCL20, ?d T cells, and IL-22 in corneal epithelial healing. FASEB J. 2011 Aug; 25(8):2659-68.
-
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009 Feb 05; 457(7230):722-5.
-
In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med. 1999 Nov 15; 190(10):1417-26.